 |
27 Diseases |  |
22 Trials |
|
22 Trials |  |
341 News |  |
| «1234567» |
- | aripiprazole / Generic mfg., bupropion sustained-release / Generic mfg.
Trial completion: VAST-D: VA Augmentation and Switching Treatments for Improving Depression Outcomes (clinicaltrials.gov) - Jun 3, 2018
P3, N=1522, Completed, Sponsor: VA Office of Research and Development
Active, not recruiting --> Completed
- | bupropion sustained-release / Generic mfg.
Trial completion date, Trial primary completion date: Smoking Cessation for People Living With HIV/AIDS (clinicaltrials.gov) - Apr 5, 2018
P=N/A, N=400, Recruiting, Sponsor: Wayne State University
Active, not recruiting --> Completed Trial completion date: Dec 2018 --> Jun 2019 | Trial primary completion date: Dec 2018 --> Jun 2019
- | Chantix (varenicline) / Pfizer
Trial completion date, Trial primary completion date: Web-based Smoking Cessation Program for Tribal College Students (clinicaltrials.gov) - Apr 4, 2018
P3, N=300, Recruiting, Sponsor: Won Choi, PhD, MPH
Trial completion date: Dec 2018 --> Jun 2019 | Trial primary completion date: Dec 2018 --> Jun 2019 Trial completion date: Mar 2018 --> Mar 2019 | Trial primary completion date: Feb 2018 --> Jun 2018
- |||| Auvelity (bupropion/dextromethorphan) / Axsome Therap
Enrollment open: AXS-05 Phase II Trial on Smoking Behavior (clinicaltrials.gov) - Apr 2, 2018
P2, N=60, Recruiting, Sponsor: James Davis
Trial completion date: Mar 2018 --> Mar 2019 | Trial primary completion date: Feb 2018 --> Jun 2018 Not yet recruiting --> Recruiting
- ||||| Auvelity (bupropion/dextromethorphan) / Axsome Therap
New P2 trial: AXS-05 Phase II Trial on Smoking Behavior (clinicaltrials.gov) - Mar 20, 2018
P2, N=60, Not yet recruiting, Sponsor: James Davis
- | bupropion sustained-release / Generic mfg.
Phase classification: Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers (clinicaltrials.gov) - Mar 13, 2018
P4, N=165, Active, not recruiting, Sponsor: VA Office of Research and Development
Not yet recruiting --> Recruiting Phase classification: P=N/A --> P4
- | bupropion sustained-release / Generic mfg.
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: CPT and Smoking Cessation (clinicaltrials.gov) - Mar 9, 2018
P2/3, N=69, Completed, Sponsor: VA Office of Research and Development
Phase classification: P=N/A --> P4 Active, not recruiting --> Completed | N=50 --> 69 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017
- | bupropion sustained-release / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Smoking Treatment and Exercise Program for Underserved Populations (STEP UP) (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=5, Completed, Sponsor: Duke University
Active, not recruiting --> Completed | N=50 --> 69 | Trial completion date: Apr 2018 --> Jul 2017 | Trial primary completion date: Apr 2018 --> Jul 2017 Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jul 2017 | Trial primary completion date: Jan 2018 --> Jul 2017
- ||||| Auvelity (bupropion/dextromethorphan) / Axsome Therap
New P2 trial: AXS-05 Phase II Trial on Smoking Behavior (clinicaltrials.gov) - Mar 1, 2018
P2, N=60, Not yet recruiting, Sponsor: James M. Davis, MD
- | Trial completion date, Trial primary completion date: Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects (clinicaltrials.gov) - Feb 19, 2018
P4, N=126, Recruiting, Sponsor: Centre hospitalier de l'Universit
Active, not recruiting --> Completed | Trial completion date: Jan 2018 --> Jul 2017 | Trial primary completion date: Jan 2018 --> Jul 2017 Trial primary completion date: Jan 2018 --> Jan 2019 | Trial completion date: Oct 2018 --> Oct 2019
- | bupropion sustained-release / Generic mfg.
Trial primary completion date: Bupropion for Smoking Cessation During Pregnancy (clinicaltrials.gov) - Feb 13, 2018
P4, N=65, Completed, Sponsor: The University of Texas Medical Branch, Galveston
Trial primary completion date: Jan 2018 --> Jan 2019 | Trial completion date: Oct 2018 --> Oct 2019 Trial primary completion date: Jul 2016 --> Dec 2016
- | Chantix (varenicline) / Pfizer
Trial completion, Trial primary completion date: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior (clinicaltrials.gov) - Feb 8, 2018
P2, N=62, Completed, Sponsor: Yale University
Trial primary completion date: Jul 2016 --> Dec 2016 Active, not recruiting --> Completed | Trial primary completion date: Jul 2016 --> Oct 2016
- | Chantix (varenicline) / Pfizer
Biomarker, Trial primary completion date: Pharmacogenetics, Emotional Reactivity and Smoking (clinicaltrials.gov) - Feb 1, 2018
P2/3, N=646, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed | Trial primary completion date: Jul 2016 --> Oct 2016 Trial primary completion date: Dec 2018 --> Dec 2019
- | bupropion sustained-release / Generic mfg.
Trial initiation date: Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya (clinicaltrials.gov) - Jan 23, 2018
P3, N=300, Not yet recruiting, Sponsor: University of Maryland
Trial primary completion date: Dec 2018 --> Dec 2019 Initiation date: Jan 2018 --> Sep 2018
- | Chantix (varenicline) / Pfizer
Trial primary completion date: Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (clinicaltrials.gov) - Dec 22, 2017
P=N/A, N=60, Recruiting, Sponsor: Wake Forest University Health Sciences
Initiation date: Jan 2018 --> Sep 2018 Trial primary completion date: Jan 2018 --> Jan 2019
- | Chantix (varenicline) / Pfizer
Enrollment open, Trial primary completion date: Treating Smokeless Tobacco Use in Rural Veterans (clinicaltrials.gov) - Dec 5, 2017
P=N/A, N=50, Enrolling by invitation, Sponsor: Mark Vander Weg
Trial primary completion date: Jan 2018 --> Jan 2019 Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Sep 2017 --> Sep 2019
- | bupropion sustained-release / Generic mfg.
New P3 trial: Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya (clinicaltrials.gov) - Nov 14, 2017
P3, N=300, Not yet recruiting, Sponsor: University of Maryland
- | bupropion sustained-release / Generic mfg.
Trial primary completion date: Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia (clinicaltrials.gov) - Nov 6, 2017
P4, N=36, Recruiting, Sponsor: Duke University
Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Sep 2017 --> Sep 2019 Trial primary completion date: Jan 2018 --> Jan 2019
- | bupropion sustained-release / Generic mfg.
Trial primary completion date: Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men (clinicaltrials.gov) - Nov 6, 2017
P2, N=70, Recruiting, Sponsor: University of Malaya
Trial primary completion date: Jan 2018 --> Jan 2019 Trial primary completion date: Apr 2017 --> Apr 2018
- | bupropion sustained-release / Generic mfg.
Trial primary completion date: Smoking Treatment and Exercise Program for Underserved Populations (STEP UP) (clinicaltrials.gov) - Nov 6, 2017
P=N/A, N=5, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Apr 2017 --> Apr 2018 Trial primary completion date: Sep 2017 --> Jan 2018
- | Chantix (varenicline) / Pfizer
Trial primary completion date: Web-based Smoking Cessation Program for Tribal College Students (clinicaltrials.gov) - Oct 26, 2017
P3, N=300, Recruiting, Sponsor: Won Choi, PhD, MPH
Trial primary completion date: Sep 2017 --> Jan 2018 Trial primary completion date: Sep 2017 --> Feb 2018
- | bupropion sustained-release / Generic mfg.
Trial primary completion date: Smoking Cessation for People Living With HIV/AIDS (clinicaltrials.gov) - Oct 26, 2017
P=N/A, N=400, Recruiting, Sponsor: Wayne State University
Trial primary completion date: Sep 2017 --> Feb 2018 Trial primary completion date: Jul 2018 --> Dec 2018
- | lithium carbonate ER / Generic mfg.
Enrollment open, Enrollment change, HEOR: Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies (clinicaltrials.gov) - Oct 13, 2017
P=N/A, N=1300000, Enrolling by invitation, Sponsor: University of New Mexico
Trial primary completion date: Jul 2018 --> Dec 2018 Not yet recruiting --> Enrolling by invitation | N=1000000 --> 1300000
- | bupropion sustained-release / Generic mfg.
Enrollment closed: Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers (clinicaltrials.gov) - Oct 9, 2017
P=N/A, N=165, Active, not recruiting, Sponsor: VA Office of Research and Development
Not yet recruiting --> Enrolling by invitation | N=1000000 --> 1300000 Recruiting --> Active, not recruiting
- | bupropion sustained-release / Generic mfg., fluoxetine / Generic mfg.
Trial primary completion date: Bupropion for Depression in ESRD Patients on Hemodialysis (clinicaltrials.gov) - Sep 14, 2017
P4, N=40, Recruiting, Sponsor: University of Arkansas
Recruiting --> Active, not recruiting Trial primary completion date: Aug 2017 --> Sep 2018
- | bupropion sustained-release / Generic mfg.
Enrollment change: Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease (clinicaltrials.gov) - Sep 13, 2017
P4, N=99, Completed, Sponsor: Eva Szigethy
Trial primary completion date: Aug 2017 --> Sep 2018 N=130 --> 99
- | bupropion sustained-release / Generic mfg.
Enrollment open: Effect of Bupropion on Seizure Threshold in Depressed Patients (clinicaltrials.gov) - Aug 29, 2017
P4, N=10, Recruiting, Sponsor: Duke University
N=130 --> 99 Not yet recruiting --> Recruiting
- | Chantix (varenicline) / Pfizer
Trial completion, Phase classification, Enrollment change: Extended Treatment for Smoking Cessation (clinicaltrials.gov) - Aug 1, 2017
P4, N=223, Completed, Sponsor: Stanford University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | N=400 --> 223
- | Chantix (varenicline) / Pfizer
New trial: Metabolism-informed Care for Smoking Cessation (clinicaltrials.gov) - Jul 24, 2017
P=N/A, N=82, Completed, Sponsor: Vanderbilt University Medical Center
- | Trial primary completion date: Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects (clinicaltrials.gov) - Jul 19, 2017
P4, N=126, Recruiting, Sponsor: Centre hospitalier de l'Universit
Active, not recruiting --> Completed | Phase classification: PN/A --> P4 | N=400 --> 223 Trial primary completion date: Dec 2016 --> Jan 2018
- | bupropion sustained-release / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Mobile Contingency Management for Marijuana and Tobacco Cessation (clinicaltrials.gov) - Jul 18, 2017
P=N/A, N=7, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Dec 2016 --> Jan 2018 Recruiting --> Active, not recruiting | N=10 --> 7 | Trial primary completion date: Aug 2018 --> Nov 2017
- | Chantix (varenicline) / Pfizer
Trial primary completion date: Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers (clinicaltrials.gov) - Jul 11, 2017
P3, N=411, Active, not recruiting, Sponsor: Mark Vander Weg
Recruiting --> Active, not recruiting | N=10 --> 7 | Trial primary completion date: Aug 2018 --> Nov 2017 Trial primary completion date: May 2017 --> Jan 2018
- | bupropion sustained-release / Generic mfg.
Trial primary completion date: Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking (clinicaltrials.gov) - Jul 11, 2017
P=N/A, N=10, Recruiting, Sponsor: Duke University
Trial primary completion date: May 2017 --> Jan 2018 Trial primary completion date: Nov 2017 --> Nov 2020
- | bupropion sustained-release / Generic mfg.
Phase classification: Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia (clinicaltrials.gov) - May 2, 2017
P4, N=36, Recruiting, Sponsor: Duke University
Trial primary completion date: Nov 2017 --> Nov 2020 Phase classification: P=N/A --> P4
- | Chantix (varenicline) / Pfizer
Trial completion: Randomized Clinical Trial to Reduce Harm From Tobacco (clinicaltrials.gov) - May 2, 2017
P=N/A, N=6006, Completed, Sponsor: University of Pennsylvania
Phase classification: P=N/A --> P4 Active, not recruiting --> Completed
- | bupropion sustained-release / Generic mfg.
Trial primary completion date: Smoking Cessation for People Living With HIV/AIDS (clinicaltrials.gov) - Apr 24, 2017
P=N/A, N=400, Recruiting, Sponsor: Wayne State University
Active, not recruiting --> Completed Trial primary completion date: Jul 2017 --> Jul 2018
- | bupropion sustained-release / Generic mfg.
New P4 trial: Effect of Bupropion on Seizure Threshold in Depressed Patients (clinicaltrials.gov) - Apr 24, 2017
P4, N=10, Not yet recruiting, Sponsor: Duke University
- |||| Chantix (varenicline) / Pfizer
Trial primary completion date: Combining Varenicline and Bupropion for Smoking Cessation (clinicaltrials.gov) - Apr 13, 2017
P3, N=385, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Trial primary completion date: Jul 2017 --> Jul 2018 Trial primary completion date: Aug 2017 --> May 2019
- | Chantix (varenicline) / Pfizer
Trial primary completion date: Web-based Smoking Cessation Program for Tribal College Students (clinicaltrials.gov) - Apr 10, 2017
P3, N=300, Recruiting, Sponsor: Won Choi, PhD, MPH
Trial primary completion date: Aug 2017 --> May 2019 Trial primary completion date: Mar 2017 --> Sep 2017
- | bupropion sustained-release / Generic mfg.
Enrollment open: Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia (clinicaltrials.gov) - Apr 4, 2017
P=N/A, N=36, Recruiting, Sponsor: Duke University
Trial primary completion date: Mar 2017 --> Sep 2017 Not yet recruiting --> Recruiting
- | Chantix (varenicline) / Pfizer
Trial primary completion date: Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (clinicaltrials.gov) - Mar 13, 2017
P=N/A, N=60, Recruiting, Sponsor: Wake Forest University Health Sciences
Not yet recruiting --> Recruiting Trial primary completion date: Jan 2017 --> Jan 2018
- | bupropion sustained-release / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Smoking Treatment and Exercise Program for Underserved Populations (STEP UP) (clinicaltrials.gov) - Feb 17, 2017
P=N/A, N=5, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Jan 2017 --> Jan 2018 Recruiting --> Active, not recruiting | N=10 --> 5 | Trial primary completion date: Mar 2018 --> Sep 2017
- Chantix (varenicline) / Pfizer
Trial primary completion date: Dissemination of a Tailored Tobacco Quitline for Rural Veteran Smokers (clinicaltrials.gov) - Feb 13, 2017
P3, N=411, Active, not recruiting, Sponsor: University of Iowa
Recruiting --> Active, not recruiting | N=10 --> 5 | Trial primary completion date: Mar 2018 --> Sep 2017 Trial primary completion date: Dec 2016 --> May 2017
- bupropion sustained-release / Generic mfg.
Trial completion, Enrollment change: Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease (clinicaltrials.gov) - Feb 2, 2017
P4, N=130, Completed, Sponsor: University of Pittsburgh
Trial primary completion date: Dec 2016 --> May 2017 Recruiting --> Completed | N=100 --> 130
- Chantix (varenicline) / Pfizer
Trial completion, Enrollment change, Real-world evidence, Real-world effectiveness, Real-world: The MATCH (Medication Aids for Tobacco Cessation and Health) Study (clinicaltrials.gov) - Feb 2, 2017
P=N/A, N=968, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed | N=100 --> 130 Recruiting --> Completed | N=1500 --> 968
- bupropion sustained-release / Generic mfg.
Enrollment open: Smoking Treatment and Exercise Program for Underserved Populations (STEP UP) (clinicaltrials.gov) - Jan 31, 2017
P=N/A, N=10, Recruiting, Sponsor: Duke University
Recruiting --> Completed | N=1500 --> 968 Not yet recruiting --> Recruiting
- bupropion sustained-release / Generic mfg.
Enrollment open: Mobile Contingency Management for Marijuana and Tobacco Cessation (clinicaltrials.gov) - Jan 31, 2017
P=N/A, N=10, Recruiting, Sponsor: Duke University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Chantix (varenicline) / Pfizer
Biomarker, Enrollment change, Trial primary completion date: Pharmacogenetics, Emotional Reactivity and Smoking (clinicaltrials.gov) - Jan 30, 2017
P2/3, N=646, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting N=375 --> 646 | Trial primary completion date: Dec 2017 --> Dec 2018
- bupropion sustained-release / Generic mfg.
Trial initiation date: Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia (clinicaltrials.gov) - Jan 26, 2017
P=N/A, N=36, Not yet recruiting, Sponsor: Duke University
N=375 --> 646 | Trial primary completion date: Dec 2017 --> Dec 2018 Initiation date: Sep 2016 --> Feb 2017
- NN1213 / Novo Nordisk
Trial completion, Phase classification, Enrollment change, Trial primary completion date: Impact of Smoking Cessation on Sleep - 5 (clinicaltrials.gov) - Jan 12, 2017
P4, N=59, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Initiation date: Sep 2016 --> Feb 2017 Recruiting --> Completed | Phase classification: P2/3 --> P4 | N=136 --> 59 | Trial primary completion date: Aug 2008 --> May 2009